<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3AAdult_NAC_dosing%2Fen</id>
	<title>Template:Adult NAC dosing/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Template%3AAdult_NAC_dosing%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Adult_NAC_dosing/en&amp;action=history"/>
	<updated>2026-04-18T22:52:37Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Template:Adult_NAC_dosing/en&amp;diff=383480&amp;oldid=prev</id>
		<title>FuzzyBot: Updating to match new version of source page</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Template:Adult_NAC_dosing/en&amp;diff=383480&amp;oldid=prev"/>
		<updated>2026-01-20T08:16:50Z</updated>

		<summary type="html">&lt;p&gt;Updating to match new version of source page&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Página nueva&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;&amp;lt;languages/&amp;gt;&amp;lt;/noinclude&amp;gt;&lt;br /&gt;
&lt;br /&gt;
====PO====&lt;br /&gt;
&lt;br /&gt;
*Less preferred than IV route due to unpleasant taste and smell&lt;br /&gt;
*140 mg/kg PO load&lt;br /&gt;
*70 mg/kg PO q4hr x17 doses additional; dilute to 5% soln&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====IV====&lt;br /&gt;
&lt;br /&gt;
*Loading dose: 150mg/kg in 100 mL D5W over 60min&lt;br /&gt;
*Second (maintenance) dose: 50mg/kg in 250 mL D5W over 4hr&lt;br /&gt;
*Third dose: 100mg/kg in 500 mL D5W over 16hr&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Comments====&lt;br /&gt;
&lt;br /&gt;
*Almost 100% effective if given &amp;lt;8 hr post-ingestion; less effective if 16-24 hr post-ingestion&lt;br /&gt;
*May still be useful &amp;gt;24 hr post-ingestion, even with fulminant hepatic failure. Give NAC until LFTs improve (not until APAP level is 0) &amp;lt;ref&amp;gt;Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol-induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026-1029. (Prospective randomized controlled trial; 50 patients)&amp;lt;/ref&amp;gt; &amp;lt;ref&amp;gt;Harrison PM, Keays R, Bray GP, et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of N-acetylcysteine. Lancet. 1990;335(8705):1572- 1573. (Retrospective analysis; 100 patients)&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Be aware NAC treatment may affect PT. May see a dose-dependent increase in PT following NAC in patients without hepatotoxicity. &amp;lt;ref&amp;gt;Wasserman GS, Garg U. Intravenous administration of Nacetylcysteine: interference with coagulopathy testing. Ann Emerg Med. 2004;44(5):546-547. (Letter)&amp;lt;/ref&amp;gt;&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>